The cluster is dominated by active/quant sellers (Point72, Two Sigma, Morgan Stanley) with a near-exit from Point72, while the sole buyer is a passive index fund. This suggests informed capital is rotating out. Monitor for further 13F filings next quarter to confirm trend; the stock may face continued selling pressure if the thesis weakens.
Executive Summary
An institutional cluster for Bicara Therapeutics (BCAX) shows net bearish conviction in Q3 2025: 3 sellers (including a near-exit from Point72) versus 1 passive buyer (Schwab). The selling is concentrated among active/quant funds, while the sole buyer is a passive index manager, suggesting the bearish signal is more informative. Total selling value ($1.6M) outweighs buying ($2.6M net, but driven by price appreciation, not conviction).
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.6M
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Schwab | ADD | +45.5% | $4.4M | $2.6M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -51.1% | $1.9M | -$320.0K |
| Two Sigma | TRIM | -29.2% | $1.2M | $255.0K |
| Point72 | NEAR_EXIT | -86.1% | $2.0M | -$1.5M |
Key Facts
- 3 sellers vs 1 buyer in Q3 2025 institutional cluster
- Point72 near-exited 86.1% of its position (from $2.0M to $476K)
- Morgan Stanley trimmed 51.1% of its stake (from $1.9M to $1.6M)
- Two Sigma trimmed 29.2% of its position
- Only buyer was Schwab (passive index fund), adding 45.5% to $4.4M
- Net dollar change across all tracked funds: -$1.6M (sellers) vs +$2.6M (buyer, largely price-driven)
Financial Impact
3 institutional sellers reduced holdings by a net of $1.6M, while 1 passive buyer added $2.6M (mostly from price appreciation). Total tracked institutional activity: $4.2M in gross turnover.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound or reversed since quarter-end
- Small absolute dollar amounts ($1-4M) may not be material for a $1.3B market cap stock
- Passive buying from Schwab could offset some selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BCAX-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 8-K | $24.73 $19.78 | ▼ −20.02% | ▼ −20.24% | — |
Aug 14, 2026 7w ago | Press Release | $24.28 $23.20 | ▼ −4.45% | ▼ −2.46% | — |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | — |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | — |
Aug 11, 2026 7w ago | 8-K | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | — |
Aug 11, 2026 7w ago | Press Release | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | — |
Jul 14, 2026 11w ago | Insider Cluster | $28.10 $23.76 | ▼ −15.44% | ▼ −17.94% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $21.28 $29.68 | ▼ −39.47% | ▼ −37.58% | — |
May 26, 2026 18w ago | Insider Cluster | $21.58 $26.34 | ▲ +22.06% | ▲ +23.96% | — |
May 11, 2026 20w ago | 8-K | $22.92 $20.56 | ▼ −10.30% | ▼ −9.99% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access